India: +91-40-42023318 | Singapore: +65-31631880
  U.S / Canada Toll Free: +1-866-259-4781
  Kenya: +254-732-300719

          

Clinical Trial News

Additions to standard multiple myeloma therapy do not appear to yield additional benefit

Largest randomized trial finds second round of chemotherapy or stem cell transplant does not improve progression-free survival.

New data shed light on potential advantages of pacritinib for patients with myelofibrosis

Pacritinib, currently on hold by the FDA, appears to be more effective in reducing spleen volume; twice-daily dose improves symptoms - this analysis comes from data before the clinical hold.

Cancer drug ibrutinib found helpful in treating graft versus host disease after transplant

Ibrutinib could be promising new option for patients who don't respond to corticosteroid treatment.

Experimental drug for spinal muscular atrophy shows promising early results, prompting phase 3 clinical trial

A new drug for spinal muscular atrophy has shown promising early results in a phase 2 trial involving 20 babies with infantile-onset spinal muscular atrophy.

Combination immune therapy shows promise against Hodgkin lymphoma

The combination of two new drugs that harness the body's immune system is safe and effective, destroying most cancer cells in 64 percent of patients with recurrent Hodgkin lymphoma, according to...

Nivolumab with chemotherapy improves response, survival in AML study patients

The immunotherapy drug nivolumab in combination with standard chemotherapy more than doubled response rates and improved overall survival in patients with acute myeloid leukemia (AML), according to...

Phase I trial shows that a drug that inhibits the Notch signalling process is active in a range of advanced cancers

A new anti-cancer drug that inhibits a key cell signalling process involved in many different cancers has shown that it is capable of stopping the progression of cancer and shrinking tumours.

Advanced soft tissue sarcomas respond to a combination of a new and an existing anti-cancer drug

Researchers working to find effective treatments for soft tissue sarcomas have discovered that combining a new anti-cancer drug with an existing one kills cancer cells not only in the laboratory...



James Lind Institute Newsletter
James Lind Institute Linkedin
James Lind Institute RSS
James Lind Institute Email Update
James Lind Institute Blog
James Lind Institute Facebook